SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Cypher Genomics Inc. announced a co-promotion agreement with Illumina Inc. and the selection of Adam Simpson as president and chief operating officer.
DJO Global Inc., the Vista-based maker of orthopedic devices, reporter second quarter net sales of $313.9 million, up 6.5 percent from the like quarter of 2013.
Pfenex Inc., a Sorrento Valley biotech firm specializing in a class of drugs called biosimilars, raised $50 million in its initial public offering July 23, selling 8.33 million shares at $6 per share.
La Jolla Pharmaceutical Co., a developer of therapeutics targeting unmet life-threatening diseases, announced a price of $10.50 per share for a planned underwritten stock offering of 4.8 million shares of common stock.
Illumina Inc. reported revenue of $448 million for the second quarter ending June 29.
La Jolla Pharmaceutical Co., a developer of therapeutics targeting unmet life-threatening diseases, intends to sell shares of common stock in an underwritten offering pursuant to its existing shelf registration statement, the company announced.
The Scripps Research Institute CEO and President Michael Marletta intends to step down, according to the organization’s board of trustees.
San Diego-based Agena Bioscience, Inc. said that Peter Dansky has joined the company as its chief executive officer and as a member of the board of directors.
AMN Healthcare Services Inc. has promoted Jeanette Sanchez to chief information officer, the company announced.
The International Trade Commission finds continued patent infringement despite products being redesigned.
The grant supports research based on biotechnology licensed from The Scripps Research Institute.
Arena Pharmaceuticals will be eligible for milestone payments.
Task orders under the contract could be worth up to $130.4 million.
BIOTECH: Co. Aims For More Clout Before Considering VC Route
A local biotech startup and its 22-year-old CEO — with support of local industry veterans — are trying a no-strings-attached funding model to finance their research on a potential cancer vaccine.
Biotech: Acquisition Boosts Clinical Readiness; Tax Rebates Offered by City
Illumina Inc. has had an eventful few days as the San Diego-based life science company acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro diagnostics, while moving a step closer to securing a tax rebate agreement with the city of San Diego.